AMED Co (ROCO:7575) Research & Development: NT$46.0 Mil (TTM As of Dec. 2025)


ROCO:7575 AMED Co Ltd ROCO:7575
52 GF Score
Price NT$18.20
GF Value NT$62.62
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is AMED Co Research & Development?

AMED Co ROCO:7575 -3.85% 52 Research & Development is NT$46.0 Mil as of Dec. 2025. GuruFocus rates ROCO:7575 with a GF Score™ of 52/100 and a GF Value™ of NT$62.62 (Possible Value Trap). The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. AMED Co's Research & Development for the six months ended in Dec. 2025 was NT$24.5 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NT$46.0 Mil.

AMED Co  (ROCO:7575) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

AMED Co Research & Development Related Terms

AMED Co Research & Development Historical Data

* Premium members only.

The historical data trend for AMED Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AMED Co Research & Development Chart

AMED Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 17.50 20.75 25.70 40.71 45.97

AMED Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.11 14.29 26.42 21.42 24.55
ROCO:7575
52GF Score
AMED Co Ltd ROCO:7575
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AMED Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$46.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NT$46.0 Mil mean?
AMED Co (ROCO:7575) has a Research & Development of NT$46.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on AMED Co and its competitors.
Is AMED Co's Research & Development too high?
AMED Co's current Research & Development is NT$46.0 Mil. Overall, AMED Co has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does AMED Co's Research & Development compare to ISRG and BDX?
AMED Co's Research & Development of NT$46.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on AMED Co and its competitors. AMED Co's current Research & Development is NT$46.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AMED Co stock overvalued right now?
Based on GuruFocus' analysis, AMED Co (ROCO:7575) is currently considered Possible Value Trap. The stock's GF Value™ is NT$62.62, compared to a current price of NT$18.20 — trading 70.9% below its estimated fair value. The current Research & Development is NT$46.0 Mil. AMED Co's overall GF Score™ is 52/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For AMED Co (ROCO:7575), the current Research & Development is NT$46.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AMED Co (ROCO:7575) Overvalued in 2026?

Based on GuruFocus' analysis, AMED Co stock appears to be undervalued. The current stock price of NT$18.20 is trading 70.9% below its estimated GF Value™ of NT$62.62. GuruFocus considers AMED Co to be Possible Value Trap.

Key valuation signals for ROCO:7575:

  • Research & Development: NT$46.0 Mil
  • GF Value™: NT$62.62 vs. price of NT$18.20 (70.9% below fair value)
  • GF Score™: 52/100 with 8 warning signs

No single metric tells the full story. See the ROCO:7575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AMED Co Business Description

Address No. 14, Wuquan 7th Road, 4th Floor-1, Wugu District, New Taipei, TWN
AMED Co Ltd is fully committed to the research and development of UV photopolymerized hydrogels. It is a professional research and development and manufacturing company of wound dressing materials, providing proper wound care solutions, and marketing the product under the brand of Heli Dressing.
52GF Score

Get the complete analysis for ROCO:7575

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$18.20
Price
NT$62.62
GF Value